Pediatric Clinical Trials Market Size to Hit USD 27.65 Billion by 2033
Global pediatric clinical trials market size is projected to grow from USD 17.37 billion in 2024 to USD 27.65 billion by 2033, driven by R&D investments, rising pediatric diseases, and strict regulations. Phase II trials dominate, with North America leading and Asia Pacific expected to grow fastest. Key players include Pfizer Inc., QPS Holdings, and LabCorp Drug Development.
© Copyright 2024. All Rights Reserved by MedPath